Despite significant improvements in data sharing for cancer clinical trials over the last 10 years, further changes are still needed to ensure patient-centered care, medical advancements, and trust in the pharmaceutical industry, say Flinders University researchers. In an article published in the Journal of Clinical Oncology, the authors call for mandated data sharing policies for all industry-sponsored oncology trials to support future research, help prevent the duplication of studies, and ensure robust reviews and analyses can take place. “Participants often enroll in clinical trials knowing that while the trial may Read More